Last reviewed · How we verify
NCT05517109
Hemodynamic in Postreperfusion Period and Functional Recovery in Acute Ischemic Stroke Patients
NA trial testing Hemodynamic goal including lower goal of systolic blood pressure in Acute Ischemic Stroke in 90 participants. Completed in 31 August 2024.
30 April 2024
Quick facts
| Lead sponsor | Northern State Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 12 March 2022 |
| Primary completion | 30 April 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Hemodynamic goal including lower goal of systolic blood pressure
Conditions studied
- Acute Ischemic Stroke — all drugs for Acute Ischemic Stroke →
- Intracranial Hemorrhage — all drugs for Intracranial Hemorrhage →
Sponsor
Northern State Medical University
Who can join
18 and older, any sex, with Acute Ischemic Stroke or Intracranial Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators are suggtesting that lower goals of systolic blood pressure after intravenous thrombolysis may reduce the risk of hemorrhagic complications and improve functional outcomes after acute ischemic stroke.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05517109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Ischemic Stroke
Currently open trials in the same condition.
- NCT07115940 — Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours · NA · recruiting
- NCT07404852 — Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemi · NA · recruiting
- NCT07361302 — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe · Phase 3 · recruiting
- NCT07436156 — SUMMIT RISE Study of Acute Ischemic Stroke Patients · Phase 4 · recruiting
- NCT07203625 — Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours · Phase 4 · recruiting
Other Northern State Medical University trials
Trials by the same sponsor.
- NCT04786652 — Fluid Responsiveness: SVV vs esSVV in Mechanically Ventilated and Spontaneously Breathing Patients · NA · completed
- NCT04325685 — The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia · NA · completed
- NCT04323150 — The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. · NA · completed
- NCT06332768 — NIV Versus HFO Versus Standard Therapy Immediately After Weaning From Mechanical Ventilation in ARDS Patients · NA · completed
- NCT04508296 — The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05517109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northern State Medical University
- Last refreshed: 30 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing